fundvisualizer.com

MFS Research International CMRICX

Performance (before sales charge)

As of 03/31/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 03/31/2024
Stock
8.73%
Non-U.S. Stock
90.20%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
1.07%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 03/31/2024

Basic materials

9.71%

Consumer cyclical

9.21%

Financial services

19.98%

Real estate

1.71%

Consumer defensive

7.31%

Health care

12.36%

Utilities

2.61%

Communication services

2.54%

Energy

4.96%

Industrials

19.20%

Technology

9.33%

Top 10 holdings

As of 03/31/2024

Novo Nordisk A/S Class B
3.58%
Linde PLC
3.44%
Schneider Electric SE
3.44%
Lvmh Moet Hennessy Louis Vuitton SE
2.68%
Nestle SA
2.40%
Roche Holding AG
2.30%
Hitachi Ltd
2.23%
TotalEnergies SE
1.74%
NatWest Group PLC
1.64%
Euronext NV
1.63%
Fund assets

$16.67 Billion

Share class

C

Morningstar category

Foreign Large Blend

Expense ratio

1.79%

Investment objective

Foreign Stock

Documents